“Lab in a loop” generative AI drug discovery
Roche / Genentech
Generative AI models that propose drug candidates, tested in the lab, with results fed back to train the models.
- Industry
- Healthcare & pharma
- Function
- Generation
- Dated
- 30 January 2025
- Source type
- company press release / blog
Measured effect, as reported
No measured effect published
Evidence strength. Describes the approach and ambition. No measured effect published.
This use case is not part of the AI Dividend Index and does not change it.
Source
Roche: AI revolutionising drug discovery and transforming patient care (opens in a new tab)
https://www.roche.com/stories/ai-revolutionising-drug-discovery-and-transforming-patient-care
Roche investor update: Genentech and NVIDIA collaboration (21 Nov 2023) (opens in a new tab)